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Abstract
Contrast echocardiography has an established role for enhancement of the right heart Doppler
signals, the detection of intra-cardiac shunts, and most recently for left ventricular cavity
opacification (LVO). The use of intravenously administered micro-bubbles to traverse the
myocardial microcirculation in order to outline myocardial viability and perfusion has been the
source of research studies for a number of years. Despite the enthusiasm of investigators,
myocardial contrast echocardiography (MCE) has not attained routine clinical use and LV
opacification during stress has been less widely adopted than the data would support. The purpose
of this review is to facilitate an understanding of the involved imaging technologies that have made
this technique more feasible for clinical practice, and to guide its introduction into the practice of
the non-expert user.
I. Imaging principles
Micro-bubbles
Two aspects of micro-bubbles are important – their gas
content and the nature of their shell. Recently-approved
micro-bubbles almost universally involve encapsulation
of a high molecular weight gas, which improves the per-
sistence of the bubble, optimising the number available in
the left heart chambers. Air has a greater propensity to dis-
solve into solution and although currently unattractive
because of loss of gas before arrival on the right side of the
heart, better encapsulation may allow its resurgence – the
benefit would be more rapid disappearance when the
bubble bursts. The nature of the shell or surface modifying
agent, which improves stability and prevents dissolution,
may become important for new targeted imaging
approaches.
Interaction of micro-bubbles and ultrasound
Even when optimal microbubble delivery to the myocar-
dium is achieved with invasive coronary [1] or aortic root
[2] injections, detection of reliable myocardial opacifica-
tion using standard 2D imaging is difficult. Whilst this
partly reflects difficulty distinguishing bright, grey scale
echo signals from the myocardial tissue from those of
micro-bubbles within the myocardial micro-circulation,
the problem is multi-factorial and has been overcome by
the development of contrast specific imaging modalities,
which exploit the unique interaction between the ultra-
sound field and micro bubbles[3] to maximise the
received contrast backscatter and minimise myocardial
tissue backscatter.
Micro-bubbles oscillate (expand and contract) in the
ultrasound field. The pattern and nature of their oscilla-
tion, and thus the nature of the backscatter signal, differs,
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depending on the acoustic power of the transmitted ultra-
sound field, which is expressed on modern ultrasound
machines as the mechanical index (MI). In general
echocardiography, the amplitude of returning backscatter
depends on the nature of the insonated structure, and is
represented by brightness on the formed image. Most
backscatter returns at the same frequency as the transmit-
ted ultrasound (fundamental frequency).
With  very low mechanical index imaging (MI < 0.1),
micro bubbles demonstrate linear oscillation, where the
contraction and expansion of the micro bubble are equal.
All returning micro bubble backscatter remains within the
range of the frequency transmitted by the transducer (the
fundamental frequency) – as for surrounding structures
(Figure 1a).
Low  mechanical index imaging (0.1 – 0.3), generates
nonlinear oscillation of the micro bubble whereby
expansion is greater than contraction. In addition to the
usual backscatter of a particular amplitude within the
range of the fundamental frequency, the bubbles also pro-
duce backscatter of (lesser) amplitude at harmonic fre-
quencies [4,5]. For example scatter from a bubble
interrogated by a 4 MHz pulse will be composed of 4 MHz
and 8 MHz sound (Figure 1b). Tissues and surrounding
structures do not produce harmonic backscatter when
imaged under low power.
When exposed to high mechanical index imaging (MI >
0.6, ie the MI used for standard imaging) the bubbles
oscillate wildly and burst. Upon destruction, micro-bub-
bles produce a brief, high amplitude signal, with good res-
olution, which is rich in harmonic signals, containing
backscatter at the second third and fourth harmonics etc
(Figure 1c). The bubble dissipates gradually following
destruction, depending upon the gas composition of the
bubble, with air-based micro-bubbles dissipating much
more rapidly. Importantly at high MI, tissues also produce
harmonics.
With standard fundamental imaging (high MI), myocar-
dial micro-bubbles are destroyed continuously, causing
apical swirling on LVO images and never replenishing the
myocardium within the beam, and thus not returning sig-
nificant myocardial backscatter. This exacerbates the
underlying difficulty of differentiating on grey scale,
between tissue backscatter and micro-bubble backscatter.
Changing to standard harmonic imaging (processing only
signals returned at the second harmonic of the fundamen-
tal frequency) significantly improves LVO, but offers little
benefit for myocardial perfusion, with ongoing bubble
destruction and sub-optimal differentiation between con-
trast and tissue, because both produce harmonics at high
power. Contrast specific imaging modalities, with the aim
of enhancing the contrast to tissue backscatter signal ratio
(CTR) are required for optimal performance of a myocar-
dial contrast study.
Contrast specific imaging technology
High Power Techniques – Intermittent Imaging
Triggered harmonic imaging
Porter demonstrated that intermittent high power imag-
ing demonstrated significantly better myocardial opacifi-
cation than continuous imaging, with the best
opacification obtained using intermittent harmonic imag-
ing [6]. During intermittent high power imaging, high
energy ultrasound is transmitted at specified intermittent
intervals, triggered to the ECG (eg once every 4 cardiac
cycles; 1:4 triggering). The time between destructive pulses
allows the micro-bubbles to replenish the myocardium.
With each destructive pulse, high amplitude backscatter
rich in harmonics is returned to the transducer, enabling
static images of myocardial perfusion.
Moreover, by incrementally increasing the triggering
intervals (continuous → 1:1 → 1:2 → 1:4 → 1:8 etc), the
rate of replenishment of the ultrasound beam over time
can be assessed both qualitatively and quantitatively.
The qualitative assessment of perfusion using intermittent
harmonic imaging can be improved by digital subtraction
of the myocardial signal, and optimized by colour coding
techniques to allow better extraction of bubble signals [7]
(Figure 2). The first human study validating myocardial
perfusion assessment by MCE with SPECT used digital
subtraction [8]. However, this approach requires careful
superimposition of each frame, and although the analysis
is becoming more automated, the processing is still per-
formed off-line.
Harmonic Power Doppler
Power Doppler technology is designed to detect motion
of blood or tissue, and is used in myocardial contrast echo
to overcome the need for off line digital subtraction [9].
As with traditional Doppler, two or more pulses are sent
successively along each scan line of the image and the
pairs of echo trains are compared for the presence or
absence of a frequency shift (indicating movement).
However, unlike traditional Doppler, power Doppler
ignores the direction and velocity of the moving structure;
if a frequency shift is detected, indicating motion of the
structure, then colour is displayed as an overlay whose sat-
uration is related to the amplitude of the echo which has
moved. If no frequency shift (movement) is detected, no
colour is displayed.
This method is ideally suited to high mechanical index
destructive imaging, as the first pulse destroys theCardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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Interaction of micro-bubbles and ultrasound Figure 1
Interaction of micro-bubbles and ultrasound.Cardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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myocardial micro-bubbles, generating a brief, high ampli-
tude echo rich in harmonics. The second pulse finds that
the bubbles have 'moved', and thus colour is overlaid on
the echo image over the areas of myocardium that con-
tained micro-bubbles. In an area with no micro bubbles,
there is no 'movement' recognised and there is no colour
overlay applied to that region. Note that the technique is
not actually detecting movement of the bubbles in the cir-
culation, but rather their destruction. This technique has
been correlated in human subjects with SPECT[10] and
has been used extensively in clinical trials (Figure 3 and
additional file 1).
The most important limitation of this technique is
motion artefact from tissue, because tissue motion will be
expressed like bubble destruction, potentially showing
perfusion when none is present (a false negative). If Dop-
pler frequency is increased, pulse separation is reduced, so
tissue movement between pulses can be minimized. How-
ever, if the pulses are too close, not all the gas within the
bubble will have dissipated before arrival of the next
pulse, so the difference between pulses is reduced, possi-
bly leading to false positive perfusion defects. Air-filled
micro-bubbles are optimal for this technique because of
rapid dissipation of the gas, allowing closely spaced
pulses.
Pulse Inversion Doppler
Another grey scale high MI technique is pulse-inversion
imaging whereby two beam mode pulses are sent in rapid
Digital subtraction and colour coding of MCE images acquired using intermittent harmonic imaging Figure 2
Digital subtraction and colour coding of MCE images acquired using intermittent harmonic imaging.Cardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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succession into the myocardium. The second pulse sent is
a mirror image of the first (i.e. 180° phase shift). The
scanner processes the consecutive returning pulses by add-
ing them together. Tissue generates a linear echo, thus the
addition of one pulse to the other should cancel out to
zero and no signal is generated. Micro-bubbles produce
non-linear echo signals and the summation of returning
pulses will not equal zero and a signal will be registered
(Figure 4).
Using this technique, processing can theoretically be lim-
ited only to signals generated by bubbles. As well as being
a grey-scale technique, tissue motion artefacts are a major
limitation, as movement of tissue also creates non-linear
Harmonic power Doppler imaging [see also additional file 1] Figure 3
Harmonic power Doppler imaging [see also additional file 1]
Pulse inversion Doppler Figure 4
Pulse inversion Doppler.Cardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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signals. Nevertheless the theory behind this technology
has led to the development of successful real time
imaging.
Ultraharmonic imaging
With the development of increased bandwidth transduc-
ers, another intermittent high MI technique has evolved
to improve the contrast to tissue ratio of backscatter.
While intermittent harmonic imaging demonstrates myo-
cardial perfusion, it is limited by the presence of tissue sig-
nals at the second harmonic. However, bubble
destruction causes backscatter at 3rd 4th and sub-harmon-
ics. At these higher harmonics the tissue signal is negligi-
ble, thus processing only backscatter from these further
harmonics enables selective enhancement of the contrast
signal. Interestingly, current ultra-harmonic imaging
involves processing signals from between the second and
third harmonic.
The strength of the high MI approaches are their sensitiv-
ity for the presence of contrast, because bubble destruc-
tion results in the highest amplitude backscatter. The
disadvantages are that they lack simultaneous assessment
of function, require reliable ECG triggering and image
acquisition, and can be both technically challenging and
time consuming (of particular importance for stress imag-
ing). While the difficulty maintaining image position with
long triggering intervals has been aided by the use of low
MI localization images, respiratory movement is almost
inevitable.
Low Power Techniques – Real Time Imaging
In recent years, technologies have been developed which
so successfully exploit the non-linear responses of micro-
bubbles, that even low amplitude micro-bubble backscat-
ter can be isolated from tissue signals for processing. This
allows continuous low power imaging to be performed,
with limited bubble destruction, enabling simultaneous
assessment of wall motion and perfusion in real time
(although frame-rate is minimized in order to reduce bub-
ble destruction) (See table 1). Hence low MI imaging is
commonly known as real time imaging,
The use of low MI has two major benefits; (1) The bubbles
undergo stable non-linear oscillation emitting continuous
fundamental and harmonic signals and (2) the tissues
themselves do not generate harmonic signals at low MI.
Like incremental triggered imaging, low MI imaging ena-
bles assessment of micro-bubble replenishment of the
myocardium over time after bubble destruction. With low
MI imaging, myocardial bubble destruction is achieved by
transmission of a series of a high MI pulses ("flashes"),
after which replenishment can be observed in real time
(see figure 11). There are 2 major real time techniques.
Power pulse inversion imaging
This technique combines the non-linear detection per-
formance of pulse inversion with the motion discrimina-
tion capability of power Doppler. Multiple transmit
pulses of alternating polarity are used, and Doppler signal
processing techniques are applied to distinguish between
bubble backscatter and backscatter from tissue. In a typi-
cal configuration, echos from a train of pulses are com-
bined in such a way that signals from moving tissue are
eliminated (see also figure 4).
Power modulation imaging
This method utilises the same signal subtraction princi-
ples, as PPI, with the transmitted pulses identical in phase
but of different in amplitude or 'power' – hence power
modulation, one impulse of full power, the other half that
power. Echos reflected from stationery tissue are linear,
thus if we subtract two times the lower power from full
power, the signals should cancel out whereas a non-linear
oscillation of micro-bubbles will generate a signal. In
power modulation, fundamental imaging is most suited,
because the tissue subtraction technique is so effective
that the best signal to noise ratio from contrast to tissue is
at the fundamental frequency. Both techniques have been
validated in animals and utilised for qualitative assess-
ment of perfusion in humans[11,12].
Table 1: Technical details and clinical implications of contrast-specific imaging techniques
High Power 
Intermittent Imaging
Acquisition 
difficulty
Amount of 
contrast used
Amplitude of 
micro-bubble 
backscatter
Dynamic 
range
Greyscale 
or colour
Processed 
Backscatter
Myocardia
l perfusion
Wall 
motion
Artefacts
Tissue Harmonic Imaging challenging low high wide grey harmonic yes no yes
Ultraharmonic challenging low high wide grey harmonic yes no yes
Pulse inversion challenging low high wide grey harmonic yes no yes++
Harmonic Power Doppler challenging low high wide colour harmonic yes no yes
Low Power Continuous 
Imaging
Power Pulse inversion easy high low narrow colour harmonic yes yes yes
Power modulation easy high low narrow either fundamental yes yes yesCardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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Bubble administration
The decision regarding the use of a bolus or infusion for
intravenous administration of micro-bubbles is depend-
ant on a variety of factors, including the type of micro-
bubble used, equipment and staff available and clinical
indication for the test (LVO, qualitative perfusion or
quantitative perfusion). For MCE, bubbles should be
infused with the aim of LV opacification and adequate
myocardial perfusion with minimal/no attenuation of the
basal segments. The amount of contrast required for this
varies from bubble to bubble, machine to machine and
technique used (intermittent or continuous), as well as
showing patient to patient variability. Ideally all studies,
particularly those assessing perfusion would involve a
continuous infusion of micro-bubbles, with a mechani-
cally controlled infusion preferable to a manually control-
led one (slow continuous injection). This enables
establishment of a true steady state for optimal imaging
and in particular quantification.
II. Left ventricular opacification
Accurate evaluation of regional and global left ventricular
function by echocardiography is dependent on adequate
endocardial border resolution. Using fundamental imag-
ing, approximately 20% of resting echos demonstrate
inadequate endocardial definition [13], defined as ≥ 2
segments not seen at baseline. While native tissue har-
monic imaging enables better endocardial definition than
standard fundamental imaging and reduces the number
of patients with inadequate studies to 5–10%, contrast
induced LVO still confers benefit over harmonic imaging
[14]. The most challenging patients have obesity, chronic
Importance of machine settings for using contrast for LV opacification Figure 5
Importance of machine settings for using contrast for LV opacification. (a) In this example, endocardial border definition is 
probably adequate with standard tissue harmonic imaging – [see additional file 2.] (b) The use of contrast for LVO with stand-
ard diagnostic harmonic imaging machine settings provides worse border definition in the lateral wall, and apical bubble 
destruction, illustrating the importance of appropriate machine settings – [see additional file 3]. Image (c) shows machine set-
tings for myocardial perfusion imaging – this provides assessment of myocardial perfusion and wall motion, but the frame rate 
for WMA is 20–25 Hz and thus subtle WMA's could be missed – [see additional file 4]. Therefore for optimal assessment of 
WMA image (d) displays specific intermediate MI imaging at high frame rate designed specifically to enhance the endocardial/
cavity border. Even in this example there is some apical swirling despite the focal zone set in the mid LV – [see also additional 
file 5].Cardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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lung disease or chest wall deformities. Ventilated patients
in intensive care also provide significant difficulties
because of patient positioning and compliance.
Techniques that enhance discrimination between myocar-
dial tissue and the blood pool may therefore improve the
clinical utility and diagnostic accuracy of echo. Left ven-
tricular opacification (LVO) by contrast echo enhances
this discrimination to better define the endocardial
surface.
Contemporary LVO involves administration of perfluro-
carbon micro-bubbles (which show superior duration of
opacification and enhancement of endocardial definition
compared with air filled bubbles [15]), and intermediate
MI harmonic imaging (0.4–0.5) which allows continuous
high frame rate imaging, results in reduced bubble
destruction, leads to production of micro-bubble har-
monic signals with minimal tissue harmonic production,
enabling maximal discrimination between the opacified
blood pool and myocardium (Figure 5 and additional
files 2, 3, 4, and 5).
LV volume measurement
While there is clear evidence that contrast LVO can
improve endocardial border definition, there are theoret-
ical reasons why this may not necessarily translate into
more accurate assessment of LV cavity size, volume and
function. Attenuation artefacts sometimes obscure the
endocardial surface, particularly in the basal segments
and myocardial contrast may confuse distinction of the
border between the blood pool and the endocardium.
Most importantly, the use of any 2-D echo technique to
assess left ventricular volumes and ejection fraction (with
or without contrast), requires a standard imaging plane.
Fore-shortened views or views not oriented through the
centre of the ventricular cavity will lead to an underesti-
mation of volume no matter how good the endocardial
border definition [16].
Notwithstanding these potential technical limitations,
contrast LVO using fundamental imaging improves the
correlation between LV volumes obtained with echo and
MRI [17]. In addition, accurate classification of systolic
function by calculated ejection fraction has been
improved from 70 to 94% by the use of contrast, with this
improved accuracy almost exclusive to patients with poor
baseline images. A subsequent study confirmed that, even
Realtime 3D echocardiography without (a) – [additional file 6], and with contrast enhancement (b) [additional file 7] Figure 6
Realtime 3D echocardiography without (a) – [additional file 6], and with contrast enhancement (b) [additional file 7]. There is 
clear benefit for LV border detection. [See also additional files 8 and 9 for real time 3-D movies without and with contrast 
respectively.]Cardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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using harmonic imaging, the measurement of LV volumes
was optimised with contrast LVO, using electron beam CT
as the standard of reference [18]. While the role of LVO for
3D imaging is currently undefined, it seems likely that this
will be an important application of contrast echo (Figure
6 and additional files 6, 7, 8 and 9).
LVO and wall motion analysis
Enhanced endocardial border definition can improve the
accuracy and inter-observer agreement for assessment of
regional wall motion at rest [19]. Compared with MRI, the
number of segments visualized was clearly improved after
contrast (86% visualised before contrast, 99% after con-
trast). In addition, identification of segments with abnor-
mal wall motion improved 82% to 100%, with the
clinical utility of the contrast being greatest at the lateral
and anterior walls. Importantly, the inter-observer agree-
ment for assessment of individual wall segments was sig-
nificantly improved and contrast also improved intra-
observer agreement for determination of normal versus
abnormal wall motion and assessment of the severity of
wall motion abnormality compared with MRI. The ability
of LVO to improve scoring and inter-observer variability
of regional wall motion at rest has important implications
for stress echocardiography.
Stress echocardiography is an established clinical tool
with a high sensitivity and specificity for the diagnosis of
coronary artery disease (CAD). During stress echo the
diagnosis of CAD is based on detection of regional con-
tractile dysfunction, and requires visualization of all myo-
cardial segments to document or exclude abnormalities
definitively. Reduced endocardial border definition is
exacerbated during stress because of chest wall movement
during hyperventilation and cardiac translational
movement during tachycardia. With fundamental imag-
ing, inadequate endocardial definition has been reported
in up to 30% of stress echos [20]. In addition, Hoffman et
al demonstrated that suboptimal studies have worse
reproducibility and a poorer inter observer variability,
with inter-institutional institutional observer agreement
as low as 43% for studies with poor image quality[21] Tis-
sue harmonic imaging, digital side by side analysis and
standardised reporting criteria have alleviated but not
overcome this problem[22].
Wall motion scoring and reproducibility during stress
echo were even improved with air filled contrast agents
and fundamental imaging[23]. Perflurocarbon filled
agents demonstrated almost complete and consistent
endocardial border definition [24], with superiority even
to tissue harmonic imaging, and the greatest improve-
ment being seen in patients with poorest image quality
(26).
Despite these clear advantages, the critical clinical ques-
tion of whether LVO actually improves the accuracy of
stress echo for diagnosis of CAD remains unanswered –
Dolan [25] came closest by investigating 229 patients
undergoing dobutamine echo followed by angiography,
the largest study of contrast stress echo (for LVO) with
angiography as the gold standard. As previously docu-
mented, the endocardial border definition and inter
observer variability was superior with contrast. Their
important finding was that there was comparable sensitiv-
ity, specificity and accuracy for the presence of coronary
disease between patients with poor resting images using
contrast LVO and those in whom standard imaging gave
good resting images. Moreover, our recent work shows
that the improvement of LVO is an important contributor
to the incremental benefit of MCE (Figure 7 and addi-
tional files 10,11,12,13,14,15,16,17,18,19,20,21,22, and
23).
Thus, left ventricular opacification by contrast echo:
(1) improves the visualization of myocardial endocardial
border definition;
(2) improves the accuracy of ventricular volume assess-
ment and estimation of ejection fraction compared with
standard fundamental and harmonic imaging.
(3) improves the ability to identify and grade resting wall
motion abnormalities
(4) provides superior endocardial visualization while
imaging at peak dobutamine stress and can enable the
accuracy of a dobutamine stress echo in a technically dif-
ficult patient to be at least as good as that of a patient with
good resting images;
(5) reduces the inter-observer variability for all of the
above.
From an economic standpoint, the use of contrast agents
during stress echo has been calculated to be cost effective
[26] with the cost of the contrast agent itself more than
offset by savings incurred by reducing downstream repet-
itive testing, improved laboratory efficiency and a lower
rate of false positive and negatives. However, the calcula-
tions are based on a formulas incorporating improved
accuracy of the technique for the diagnosis of CAD, com-
pared with standard imaging, which remains un-proven.
In summary, the use of contrast for LVO is justified for
standard or stress imaging of technically difficult patients,
and possibly, for calculation of ventricular dimensions in
patients whom accurate quantitative serial follow up is
critical, eg. chemotherapy or valvular heart disease. OtherCardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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End systolic frames of 4CV at rest (left) and post stress (right) Figure 7
End systolic frames of 4CV at rest (left) and post stress (right). Note there is no obvious difference in the shape of the cavity 
on the grey scale images. Importantly, the LVO images demonstrate a clear change in shape with the basal and mid lateral seg-
ments lagging, suggestive of LCx stenosis. In addition, the mid lateral segment has a perfusion defect which was not present at 
rest. Subtotal occlusion of the LCx was demonstrated at angiography. [See also additional files 10-23 for entire study].Cardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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clinical uses of contrast for left ventricular opacification
include confirming or excluding the presence of left ven-
tricular thrombus and delineating other left ventricular
structures like pseudoaneurysm, apical hypertrophic car-
diomyopathy (Figure 8 and additional files 24,25), and
non-compacted left ventricles [27-29].
III. Myocardial contrast echocardiography
The ischaemic cascade
In the ischaemic cascade, hypoperfusion precedes wall
motion abnormalities, which precede ECG changes and
the onset of chest discomfort [30]. Stress echo, which pro-
vides an indirect marker of hypo-perfusion by recognition
of wall motion abnormalities, is more than 80% sensitive
and specific for detection of CAD [20]. The technique has
two groups of limitations;
1) Interpretive. Wall motion analysis is fundamentally
subjective [31], leading to the need for specific training
and discordance between observers. There are particular
problems in the assessment of the inferoposterior wall.
2) Dependence on the induction of ischaemia (increased
myocardial oxygen demand) to provide diagnostic
information. Many problems spring from this – depend-
ence on performance of adequate stress, influence by beta
blockade, limited sensitivity for mild (eg single vessel)
CAD, poor capacity to identify the extent of CAD (eg. 50%
sensitivity for the detection of multi vessel disease)[32].
SPECT perfusion imaging is the best-established clinical
method to address perfusion directly and theoretically
should be more sensitive than stress echo because hypop-
erfusion occurs earliest the ischaemic cascade. However,
the difference between the methods is marginal because
of the technical limitations of SPECT scanning, which also
relies on subjective interpretation.
If technically feasible there is clear role for echocardiogra-
phy to assess myocardial perfusion. Ultrasound is more
widely available, portable, avoids radiation and has a
better spatial resolution than SPECT scanning (up to 1
mm, compared with >10 mm). An ideal technique would
allow assessment of myocardial perfusion and wall
motion simultaneously.
Coronary circulatory physiology
Understanding the pathophysiology of normal myocar-
dial perfusion is essential for understanding detection of
CAD with MCE. Contrast micro-bubbles act as pure intra-
vascular tracers, traversing the myocardial vasculature,
and contrasting with MRI tracers (which escape into the
extravascular space) and radionuclides (which enter
myocytes).
Myocardial blood volume
The coronary blood volume (CBV) encompasses the
entire coronary system, which includes the epicardial
arteries, the arterioles, the capillary network, venules,
veins and the coronary sinus. Approximately one-third of
the CBV resides within the ventricular myocardium. This
myocardial blood volume (MBV) includes "microvessels"
of < 300 microns in diameter, with approximately 90% of
the total myocardial blood volume lying within the capil-
Use of contrast echo to identify a patient with apical HCM Figure 8
Use of contrast echo to identify a patient with apical HCM. Note the 'spade shaped LV cavity' on the contrast image [See also 
additional files 24 and 25]Cardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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laries (6–7 microns in diameter)[33]. Assessment of myo-
cardial perfusion with MCE involves processing
backscattered signals received from micro-bubbles within
the MBV, so that myocardial opacification almost entirely
reflects backscatter from micro-bubbles flowing through
the myocardial capillary compartment.
There are 2 components of this myocardial blood flow
appreciated with MCE i) the intensity of the backscatter
signal from the micro-bubbles within the myocardium
(brightness of its appearance on echo) – related to the
myocardial blood volume, ii) the rate of increase in inten-
sity after bubble destruction reflects the red blood cell
velocity. Their product, represents myocardial blood flow.
The response of MBF myocardial blood flow and it's com-
ponents to stress is central to the application of perfusion
imaging.
Normal physiology of perfusion
Because of the near complete extraction of O2 from red
cells by the myocardium under basal conditions, any
increase in myocardial O2 demand must rapidly translate
into increases in coronary blood flow. In the absence of a
coronary stenosis, when myocardial O2 demand is
increased, there is sufficient vasodilator reserve to allow
coronary flow to increase by a factor of 4–6 fold above
resting levels.
The work of Kaul, Wei and Lindner at the University of
Virginia has shown that the ability to increase coronary
flow in response to increased demand is achieved through
a process of coronary autoregulation, controlled predom-
inantly by the arterioles (See table 2). The coronary micro-
circulation strives to maintain a minimum trans-capillary
pressure of approximately 30 mmHg. In the absence of a
coronary stenosis, a resting patient with a mean aortic
pressure of 90 mmHg will have a pre-capillary pressure of
~45 mmHg. This natural resistance between the aorta and
the capillaries (of ~45 mmHg) is provided by the arteri-
oles[34] which present up to 60% of the total coronary
vascular resistance. In the presence of increased myocar-
dial oxygen demand, there is arteriolar vasodilation,
reducing the resistance at the arteriolar level, which ena-
bles a higher precapillary pressure, translating into
increased red blood cell velocity across the capillary net-
work, and opening dormant capillary networks in order to
maintain mean trans-capillary pressure, thus increasing
the overall myocardial blood volume. Hence overall
myocardial blood flow is increased. Importantly, pure
vasodilator stress tends to increase red cell velocity with-
out marked changes in overall myocardial blood volume.
In the presence of a significant, non-critical (60–90%)
epicardial artery stenosis at rest, completely normal rest-
ing blood flow is maintained by arteriolar vasodilation.
As a result myocardial perfusion imaging techniques can-
not detect defects at rest in patients with non-critical
stenoses.
Thus identification of perfusion defects in the setting of a
non-critical coronary stenosis requires stress imaging to
induce either ischaemia (increased myocardial oxygen
demand) or hyperaemia (pharmacologically induced
maximal arteriolar vasodilation). During stress we expect
a 4–6 fold increase in flow to areas supplied by non-sten-
otic arteries, mediated by arteriolar vasodilation,
increased red cell velocity and increased myocardial blood
volume (opening of dormant capillary networks). Flow in
the perfusion bed subtended by a significantly stenosed
artery is not augmented, as resting arteriolar vasodilation
is present, so limited augmentation of flow can be
achieved with hyperaemia. In some cases the pre-capillary
pressure drops significantly due to low distal coronary
pressure and steal. With reduced pre-capillary pressure the
only means of attempting to maintain normal trans-capil-
lary pressure is to shut down capillary networks which
were previously open (capillary de-recruitment). The net
result is that direct comparison between regions sub-
tended by a significant stenosis and normal territories
reveals perfusion mismatch.
In the presence of a critical stenosis, maximal arterial
vasodilation maintains perfusion at rest. Any further
reduction in distal coronary pressure directly translates
into reduced precapillary pressure and reduced myocar-
dial blood flow. Patients with critical lesions commonly
have collateral vessels, making assessment of resting per-
fusion a complex phenomenon.
Qualitative assessment of myocardial contrast for 
diagnosis of CAD
There are three aspects to myocardial contrast opacifica-
tion – signal intensity (equivalent to myocardial blood
volume), pattern of filling and rate of filling.
Signal intensity
Myocardial blood volume is the easiest parameter to inter-
pret qualitatively, and most studies have addressed differ-
ences in MBV between rest and stress in myocardial
segments. Perfusion has traditionally been scored using a
graded scale; 1 for homogenous perfusion, 0.5 for reduced
perfusion and 0 for absent perfusion [8]. The presence of
a stress induced perfusion defect not seen on the resting
images indicates ischaemia, but in the absence of destruc-
tion-replenishment imaging, may appear normal in mild
disease. The presence of a resting perfusion defect signifies
infarction or artefact, with an infarction likely if there are
associated regional wall motion abnormalities at rest, and
if the defect conforms to the distribution of a coronary
vascular territory.Cardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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False positive defects often reflect technical limitations
(Figure 9). Failure to obtain signal from a segment may be
due to attenuation by overlying contrast, shadowing by
rib or other structure, bubble destruction (especially in
the apex) or failure to deliver sufficient contrast to enter
the microcirculation.
Perfusion distribution
While most infarctions are shown as a transmural per-
fusion defect, stress-induced defects are often restricted to
the subendocardium (Figure 10a,10b). The detection of
this finding allows a greater level of confidence than does
a transmural defect, or particularly epicardial defects
(which may be artefactual).
The location of a defect has an important relationship to
its likelihood of being a true or a false positive. Generally,
defects on the left hand side of the image are most likely
to be true positives and those restricted to the right side
(anterior, lateral wall) should be considered very critically
before they are identified as abnormal, as these are the
most common sites of false positives. Fortunately, in our
experience the apex is a more sensitive marker of LAD dis-
ease than the anterior wall, and is usually well seen.
Likewise, a lateral segment should be matched with a pos-
terior wall finding before circumflex disease is reported.
The basal segments are also problematic – especially with
low MI imaging – and in our experience, the basal inferior
wall should be matched to an adjacent abnormal segment
(basal septum, mid-inferior) to reduce false positive
interpretations.
Table 2: Relationship between stenosis severity and stress on capillary pressure, myocardial blood volume and red cell velocity. 
Arbitrary numbers given for illustrative purposes only.
Distal coronary 
artery pressure
Arteriolar resistance Pre-capillary 
pressure
Trans-capillary 
pressure
RBC velocity MBV
No stenosis REST 90 mm Hg Normal 45 mmHg 45 mmHg 30 mmHg Normal Normal
No stenosis STRESS 90 mm Hg ↓ Maximal 25 mmHg 65 mmHg 30 mmHg ↑↑
Stenosis REST 75 mm Hg ↓ Sub-maximal 30 mmHg 45 mmHg 30 mmHg Normal Normal
Stenosis STRESS 60 mm Hg ↓ Maximal 25 mmHg 35 mmHg 30 mmHg ↓↓
False positive defects with real-time MCE Figure 9
False positive defects with real-time MCE. Pseudo-apical defects are due to apical bubble destruction (a). Relocation of the 
focus from the base toward the apex (b) leads to "resolution" of the apical abnormality, but use of a mid-ventricular focus 
placement may lead to more problems with definition of the basal segments. This case also exemplifies attenuation of the basal 
lateral segment by contrast within the LV cavity.Cardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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The shape of the LV cavity is a clue to true positive find-
ings. A "C-shaped" perfusion defect in the inferior wall
(Figure 10c) is a common distribution with right coronary
disease. Irregularities of the walls (Figure 10b) or apex
(Figure 10a) or apical "beaking" (Figure 10c) may provide
evidence of dyssynchrony, and are often associated with
subendocardial perfusion abnormalities.
Contribution of regional shape changes to the identification of perfusion defects, including irregular wall contour in the apex (a)  and mid-inferior segment (b), both associated with subendocardial defects Figure 10
Contribution of regional shape changes to the identification of perfusion defects, including irregular wall contour in the apex (a) 
and mid-inferior segment (b), both associated with subendocardial defects. The C shape of the basal inferior segment comple-
ments the diagnosis of a perfusion defect in this segment. (c)
Destruction replenishment imaging with real time MCE – see text Figure 11
Destruction replenishment imaging with real time MCE – see text.Cardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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Rate of filling
The rate of replenishment after bubble destruction is
dependent on coronary flow, and even if this is not quan-
tified, rate of refill is a reliable and sensitive marker of a
true positive defect. Using low MI techniques, micro-bub-
bles are infused until adequate LVO and myocardial
opacification are achieved (Figure 11b). Several pulses of
high mechanical index are delivered (Figure 11c), causing
destruction of micro-bubbles in the beam elevation, such
that the previously opacified myocardium is now empty
(Figure 11d). The replenishment time of micro bubbles
into the myocardium can be observed qualitatively (Fig-
ure 11e,11f,11g,11h).
As the mean myocardial microbubble velocity is 1 mm/
sec, and the beam elevation is approximately 5 mm, it
would take up to 5 seconds (ie 5–6 heart beats at a resting
heart rate from 60–80) for homogenous opacification of
the myocardium at rest. With hyperaemia in the absence
of stenosis, myocardial blood flow should increase 4–6
fold. Thus, images taken within 1–2 seconds following
bubble destruction (ie 2–3) heart beats at a peak heart rate
of 140) should demonstrate complete homogenous refill
within this time frame, and failure to fill in a perfusion
defect thus represents reduced myocardial blood flow.
Perfusion defects noted on the post stress images, not evi-
dent on the resting images suggest ischaemia [35]. -see fig-
ures 12, 13 and 14 (and additional files
26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,
44,45,46,47,48, and 49) for evidence of LAD, RCA and
multi-vessel CAD respectively. Assessment of end-systolic
frames is preferable, despite the presence of more coro-
nary flow in diastole, because the myocardium is thicker
and there is less risk of contamination by the blood pool,
and perhaps also because the capillary network is 'sealed'
during systolic contraction with minimal flow in or out of
the capillary compartment [36].
A clear apical defect is evident 2 beats post flash at peak stress (bottom line) which was not evident at rest (top line), consist- ent with LAD stenosis Figure 12
A clear apical defect is evident 2 beats post flash at peak stress (bottom line) which was not evident at rest (top line), consist-
ent with LAD stenosis. [See additional files 26-39 for full case movies, additional file 40 for angiogram and additional file 49 for 
curve fits].Cardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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High MI techniques apply the same principles, with infu-
sion until homogenous myocardial opacification. Imag-
ing is then changed to a sequential intermittent mode,
beginning with continuous high MI imaging (which
results in bubble destruction and empties the myocar-
dium). Images are then recorded intermittently, gated
from the ECG (usually end systolic) with an incrementally
lengthening triggering interval, ie 1:1 an image every car-
diac cycle, then 1:2, and image every two cardiac cycles,
then 1:3, 1:4 etc. The same principles are used for assess-
ment of perfusion defects. A perfusion defect evident on
1:2 or 1:3 triggering at peak stress not seen at 1:5/6 trigger-
ing at rest is significant and reflects an ischaemic response
to stress.
Validation of qualitative contrast echo for diagnosis of 
CAD
Qualitative assessment of perfusion with MCE was vali-
dated in open chest dogs using graded coronary stenosis
[37]. The original landmark paper in humans [8] com-
pared MCE (intermittent harmonic MCE with offline
digital subtraction and colour coding) with sestamibi
SPECT scanning in 30 patients undergoing dipyridamole
stress to investigate known or suspected coronary disease.
Normal segments showed a 91% concordance, and
abnormal segments an 85% concordance, with 90% con-
cordance by vascular territory. There was an overall 86%
concordance for the detection of coronary disease. Subse-
quent studies have validated MCE following vasodilator
or dobutamine stress using other imaging modalities,
including power Doppler and real time power pulse inver-
sion/power modulation in animals and in humans have
produced similar results to SPECT [38-40]. A recent study
A basal and mid inferior defect is evident 2 beats post flash at peak stress which was not evident at rest, consistent with RCA  stenosis Figure 13
A basal and mid inferior defect is evident 2 beats post flash at peak stress which was not evident at rest, consistent with RCA 
stenosis. [See additional files 41-46 for movies and 47 and 48 for angiography].Cardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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using real time imaging was the first to report the use of
MCE with exercise stress [41] (which is technically chal-
lenging because of cardiorespiratory movement and short
duration of hyperaemia) and again demonstrated con-
cordance between MCE and SPECT imaging. There was a
76% agreement between MCE and SPECT and an 88%
agreement between the combination of wall motion and
MCE with SPECT. This study incorporated the wall
motion data from real time imaging, and despite the low
frame rate, the results hint at the incremental benefit of
combining the approaches.
While numerous studies examining various stress and
imaging modalities have demonstrated concordance
between MCE and SPECT, there remains a paucity of data
using quantitative coronary angiography (QCA) as the
gold standard. The presence and extent of CAD by QCA
has traditionally been used as the reference standard for
the assessment of CAD, but few studies have compared
MCE and angiography (Table 3) [42]. In 45 patients
undergoing mainly dobutamine stress echocardiography,
Cwajg et al showed real time contrast-enhanced imaging
was more sensitive than standard stress echocardiography
(87% vs 56%), and gave a better recognition of disease
extent (85% vs 39%). These results were surprisingly unfa-
vourable for standard imaging, perhaps reflecting the
limitations of lower frame-rate for real-time imaging.
Moreover, no specificity data were available from this
study. In the study of exercise stress (41), only 44 of the
100 patients who had MCE and SPECT proceeded to ang-
iography, and in this group, the sensitivity and specificity
of wall motion and MCE were not significantly different.
In a recent study of 85 prospectively recruited patients, the
largest involving quantitative coronary angiography, we
demonstrated the addition of contrast (for LVO and
MCE), to standard ExE significantly enhanced the sensitiv-
ity of the test for detection of CAD from 74 to 91%, with
a non-significant reduction in specificity (57).
On the 4CV, an apical and a subendocardial basal infero-septal defect are evident 2 beats post stress Figure 14
On the 4CV, an apical and a subendocardial basal infero-septal defect are evident 2 beats post stress. The lateral wall is affected 
by artefact. On the 2CV, there is hypoperfusion of the inferior wall and subendocardial apical defect on the post stress images. 
This is consistent with multi-vessel disease.Cardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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Quantitative myocardial contrast echo for diagnosis of 
CAD
Like stress echo and nuclear perfusion imaging, MCE is
also limited by the qualitative nature of the interpretation.
Subtle differences in video intensity between vascular
beds may not be visually evident, potentially reducing the
sensitivity for the detection of stenosis. Quantitative
methods may help to alleviate this limitation and possi-
bly reduce intra-observer and inter-observer variability in
assessment.
The process of quantitative myocardial contrast echo was
validated in open chest dogs using intermittent imaging,
and the same destruction-replenishment approach is used
for contemporary qualitative assessment [43]. At a steady
state during continuous intravenous infusion of micro
bubbles, the number of bubbles entering or leaving any
capillary unit is constant and depends on the flow rate of
the bubbles. If the micro bubbles are destroyed at time
zero, the video intensity in a selected myocardial region is
close to zero dB (black). With time, bubbles will replenish
Table 3: Myocardial contrast echo studies with patients undergoing coronary angiography.
Author CAD No CAD Sensitivity MCE Specificity MCE Frequency of angiography
Cwajg [42] 32 13 87% _ All 45
Shimoni [41] 28 16 75% 100% 44 (44%) of 101
Heinle [10] 12 3 75% 67% 15 (12%) of 123
Wei [43] 15 - 100% - 15 (28%) of 54
Rocchi [55] 12 - 89% - 12 (48%) 25
Olszowska [56] 44 - 97% - All 44
Moir [57] 43 27 91% 70% 70 of 85
The raw signal intensity data from the apical septal segment is plotted against time after destruction Figure 15
The raw signal intensity data from the apical septal segment is plotted against time after destruction.Cardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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the beam elevation – the degree of replenishment into the
beam elevation increases as the time after destruction is
increased until eventually the entire ultrasound beam ele-
vation is replenished and a plateau is reached, whereby no
further increase in video-intensity/brightness can occur
(Figures 15 and 16). Because this relationship was
originally described with intermittent imaging, it is usu-
ally described in terms of video-intensity vs pulsing
intervals.
The video intensity vs pulsing interval or time curve
resembles an exponential growth function that can be fit-
ted by the equation I = A (1-e-βt) where y is the video
intensity at the pulsing interval or time t, A is the plateau
video intensity and β represents the rate of rise of the
slope. In this model the plateau myocardial video intensity
(A) represents the myocardial blood volume. The rate of
rise of the slope (β) represents the mean myocardial red
blood cell velocity and their product (A*β) represents
myocardial blood flow. Wei demonstrated an excellent
linear relationship between absolute myocardial blood
flow measured with radiolabelled microspheres and myo-
cardial contrast echo derived myocardial blood flow.
While ECG gated intermittent triggered harmonic imaging
was used to validate these measurements, both power
Doppler and real time techniques have subsequently
demonstrated similar results in animal experiments ([44-
46]).
More recently, Wei evaluated the ability of MCE to calcu-
late flow reserves from these measurements in humans
([47]), using intermittent imaging in 30 selected patients
undergoing coronary angiography (11 of whom had no
CAD and 19 had non-critical single vessel stenoses).
Quantitative MCE and invasive measurement coronary
flow (Doppler flow wire) were performed at rest and fol-
lowing vasodilator stress. In the normal subjects, myocar-
dial blood flow velocity (β) and myocardial blood flow
(A*β) reserves demonstrated a linear relationship to
coronary blood flow reserve measured invasively. In
patients with CAD, there were significant differences in
MBF velocity reserves between patients with mild
moderate and severe stenoses, and a MBF velocity reserve
of < 1.8 indicated a >70% stenosis. Thus MBF reserve
appears to be a feasible non-invasive measure of CBF
reserve in humans, which may allow non-invasive assess-
an exponential function curve is applied to allow calculation of A, beta and A*beta Figure 16
an exponential function curve is applied to allow calculation of A, beta and A*beta.Cardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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ment of CAD and micro-vascular dysfunction. More
recently, Dawson investigated the use of quantitatively
derived MBF reserves to diagnose CAD using SPECT as the
gold standard. She demonstrated moderate feasibility,
with quantitative MBF reserves from both high and low
MI imaging able to identify perfusion defects ([48]). Low
MI imaging had a lower sensitivity.
Contrast Echo and myocardial viability in chronic CAD
It is now well recognised that regional or global ventricu-
lar dysfunction does not necessarily imply irreversible
necrosis. Hypokinetic, akinetic or dyskinetic, yet viable
myocardium may be stunned or hibernating. Myocardial
stunning occurs after a period of acute ischaemia, despite
restoration of completely normal blood flow. The natural
history of stunning is of spontaneous improvement in the
viable myocardium over time. Hibernating myocardium
is the term used to describe the presence of significant
ventricular dysfunction in patients with chronic CAD,
which recovers after revascularisation. Improvement in
function of sufficient numbers of viable but hibernating
segments is associated with symptomatic benefit and
improved survival[49]. Sadly, many patients with chronic
CAD and LV dysfunction have minimal viability, and
revascularisation of these patients is associated with sig-
nificant risk, minimal benefit and possibly worse
outcome, hence the need for a reliable test for identifica-
tion of viability.
Radionuclide scanning, dobutamine echocardiography,
MRI and PET scanning are currently available modalities,
each with various advantages and disadvantages but sim-
ilar efficacy for prediction of myocardial functional recov-
ery after revascularization. MCE may also have an
important role in this clinical setting. Viable myocardium
is associated with preservation of the micro-vasculature,
and as micro-bubbles act as pure intra-vascular tracers, the
presence of myocardial perfusion by any MCE technique
at rest implies viability (see figure 17). Using intra-coro-
nary injection of bubbles, Nagueh demonstrated MCE
was feasible and had similar accuracy to thallium SPECT
and dobutamine echo for identification of functional
recovery[50]. Using intravenous micro-bubble adminis-
tration, MCE demonstrated comparable efficacy to SPECT
and DSE. Importantly in both of these studies quantitative
MCE was superior to qualitative assessment[51].
Unfortunately there remains a paucity of further data in
this clinically important area.
Safety of contrast echocardiography
The incidence of reported adverse events in human trials
(mainly investigating LV opacification) has been very low.
There have been particular theoretical concerns raised
about histologic abnormalities and cardiac marker
elevation in animals with high MI imaging[52], and
whilst serum tropinin levels are normal in humans after
high MI imaging[53], recent work has demonstrated tro-
ponin I and myoglobin in coronary sinus samples of
humans after high MI imaging[54].
In recent months the agent SonoVue (a phospho-lipid
shell encapsulating sulphur hexafluoride gas), approved
in Europe, was withdrawn from clinical use because of
adverse events including fatalities related to idiosyncratic
hypersensitivity reactions. At this stage, specific details
about the dose of agent and imaging modality used in
these cases is not available.
IV. Conclusion
Advances in micro-bubble development, combined with
the development of contrast specific imaging modalities
have enabled not only excellent LVO, but reliable
qualitative and quantitative assessment of myocardial
perfusion by ultrasound, following intravenous injections
of micro-bubbles. Use of this technology during stress
echo increases sensitivity and improves the non-invasive
evaluation of CAD.
Resting apical 2-chamber view, 10 beats post-flash, demon- strating absent perfusion to the anterior myocardial wall Figure 17
Resting apical 2-chamber view, 10 beats post-flash, demon-
strating absent perfusion to the anterior myocardial wall.Cardiovascular Ultrasound 2004, 2:15 http://www.cardiovascularultrasound.com/content/2/1/15
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